immunity. It plays a key role in cytosolic DNA mediated IFN production. STING is the direct sensor of cyclic dinucleotides(CDN) in cytosol, including c-di-GMP from pathogen and cGAMP synthesized by cGAS after DNA stimulating. After binding to and activated by CDNs, STING recruits and activates TBK1 and IRF3 by its C terminal tail. IRF3 is phosphorylated and then dimerize to enter nucleus, resulting in type I interferon (IFN ) production.
STING (Stimulator of Interferon Genes, also known as ERIS, MITA and MPYS) is an important adaptor protein in innate
immunity. It plays a key role in cytosolic DNA mediated IFN production. STING is the direct sensor of cyclic dinucleotides(CDN) in cytosol, including c-di-GMP from pathogen and cGAMP synthesized by cGAS after DNA stimulating. After binding to and activated by CDNs, STING recruits and activates TBK1 and IRF3 by its C terminal tail. IRF3 is phosphorylated and then dimerize to enter nucleus, resulting in type I interferon (IFN ) production.
5,6-dimethylxanthenone-4-acetic acid (DMXAA) and 10-carboxymethyl-9-acridanone (CMA) were identified as antitumor/antiviral compounds which acted very well in mouse model but failed in human clinical trial. Further research showed that DMXAA and CMA bind to and activate mouse STING, but not human STING. To further investigate the mechanism of ligands' species selectivity, we studied on human STING(hSTING), rat STING(rSTING) and mouse STING(mSTING) by functional and structural analysis. We found that human and rat STINGs display more similar signaling profiles toward DMXAA and CMA than that of human and mouse STINGs, suggesting that rat is more suitable for preclinical testing of STING-targeted drugs.
Previous research showed that a single point mutation in hSTING S162A renders hSTING sensitive to DMXAA. Through Taken together, our findings suggest better animal model for STING-targeted drugs and shed light on optimization of hSTING agonist.
